Progress of the tumorigenic mechanism of neutrophil and its relevance to pre-metastatic niche

doi:10.3760/cma.j.issn.1673-422X.2017.11.010

Abstract

Abstract: The tumorassociated neutrophils (TANs) are thought to be important and complicated character in tumor microenvironment. TANs play dual roles of antitumor or tumorpromoting in tumor microenvironment under different factors. TANs can not only play the antitumor effect by killing tumor cells directly and promoting immune response, but also can act as tumor promotors by promoting tumor angiogenesis and mediating tumor invasion and metastasis. Recent researches find that TANs are closely related to premetastatic niche (PMN), which can promote the construction and maintenance of PMN by means of changing the content of cell factors like interferon-γ.

Key words: Neutrophils, Neoplasms, Pre-metastatic niche

吴玉亮，程忠平. Progress of the tumorigenic mechanism of neutrophil and its relevance to pre-metastatic niche[J]. Journal of International Oncology, 2017, 44(11): 846-848.

References

［1］ Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more［J］. Nat Rev Cancer, 2016, 16(7): 431-446. DOI: 10.1038/nrc.2016.52. ［2］ Fridlender ZG, Sun J, Kim S, et al. Polarization of tumorassociated neutrophil phenotype by TGFbeta: "N1" versus "N2" TAN［J］. Cancer cell, 2009, 16(3): 183-194. DOI: 10.1016/j.ccr.2009.06.017. ［3］ Fridlender ZG, Albelda SM. Tumorassociated neutrophils: friend or foe?［J］. Carcinogenesis, 2012, 33(5): 949955. DOI: 10.1093/carcin/bgs123. ［4］ Andzinski L, Kasnitz N, Stahnke S, et al. Type Ⅰ IFNs induce antitumor polarization of tumor associated neutrophils in mice and human［J］. Int J Cancer, 2016, 138(8): 1982-1993. DOI: 10.1002/ijc.29945. ［5］ Galdiero MR, Garlanda C, Jaillon S, et al. Tumor associated macrophages and neutrophils in tumor progression［J］. J Cell Physiol, 2013, 228(7): 1404-1412. DOI: 10.1002/jcp.24260. ［6］ Raghuwanshi SK, Su Y, Singh V, et al. The chemokine receptors CXCR1 and CXCR2 couple to distinct G proteincoupled receptor kinases to mediate and regulate leukocyte functions［J］. J Immunol, 2012, 189(6): 28242832. DOI: 10.4049/jimmunol.1201114. ［7］ Henkels KM, Frondorf K, Gonzalezmejia ME, et al. IL8induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3)［J］. FEBS Lett, 2011, 585(1): 159-166. DOI: 10.1016/j.febslet.2010.11.031. ［8］ UribeQuerol E, Rosales C. Neutrophils in cancer: two sides of the same coin ［J］. J Immunol Res, 2015, 2015: 983698. DOI: 10.1155/2015/983698. ［9］ Granot Z, Fridlender ZG. Plasticity beyond cancer cells and the "immunosuppressive switch"［J］. Cancer Res, 2015, 75(21): 4441-4445. DOI: 10.1158/0008-5472.can-15-1502. ［10］ Murdoch C, Monk P, Finn A. Cxc chemokine receptor expression on human endothelial cells［J］. Cytokine, 1999, 11(9): 704-712. DOI: 10.1006/cyto.1998.0465. ［11］ Curtis VF, Wang H, Yang P, et al. A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer［J］. PLoS One, 2013, 8(1): e54916. DOI: 10.1371/journal.pone.0054916. ［12］ Deryugina EI, Zajac E, Junckerjensen A, et al. Tissueinfiltrating neutrophils constitute the major in vivo source of angiogenesisinducing MMP-9 in the tumor microenvironment ［J］. Neoplasia, 2014, 16(10): 77188, DOI:10.1016/j.neo.2014.08.013. ［13］ Deryugina EI, Quigley JP. Tumor angiogenesis: MMPmediated induction of intravasation and metastasissustaining neovasculature［J］. Matrix Biol, 2015, 44-46: 94-112. DOI: 10.1016/j.matbio.2015.04.004. ［14］ Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis［J］. Cell, 2017, 168(4): 670-691. DOI: 10.1016/j.cell.2016.11.037. ［15］ Spiegel A, Brooks MW, Houshyar S, et al. Neutrophils suppress intraluminal NK cellmediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells［J］. Cancer Discov, 2016, 6(6): 630-649. DOI: 10.1158/2159-8290.CD-15-1157. ［16］ CoolsLartigue J, Spicer J, Mcdonald B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis［J］. J Clin Invest, 2013, pii: 67484. DOI: 10.1172/JCI67484. ［17］ Peinado H, Zhang H, Matei IR, et al. Pre-metastatic niches: organspecific homes for metastases［J］. Nat Rev Cancer, 2017, 17(5): 302-317. DOI: 10.1038/nrc.2017.6. ［18］ Becker A, Thakur BK, Weiss JM, et al. Extracellular vesicles in cancer: celltocell mediators of metastasis［J］. Cancer cell, 2016, 30(6): 836-848. DOI: 10.1016/j.ccell.2016.10.009. ［19］ Liu Y, Gu Y, Han Y, et al. Tumor exosomal RNAs promote lung premetastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils［J］. Cancer Cell, 2016, 30(2): 243-256. DOI: 10.1016/j.ccell.2016.06.021. ［20］ Wculek SK, Malanchi I. Neutrophils support lung colonization of metastasisinitiating breast cancer cells［J］. Nature, 2015, 528(7582): 413-417. DOI: 10.1038/nature16140. ［21］ Yan HH, Pickup M, Pang Y, et al. Gr1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung［J］. Cancer Res, 2010, 70(15): 6139-6149. DOI: 10.1158/00085472.CAN-10-0706. ［22］ Wu CF, Andzinski L, Kasnitz N, et al. The lack of type Ⅰ interferon induces neutrophilmediated premetastatic niche formation in the mouse lung［J］. Int J Cancer, 2015, 137(4): 837-847. DOI: 10.1002/ijc.29444.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.